AKER Stock UPDATES Akers Biosciences (AKER) 3.69 08/02/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2014 at 1:40 PM

Akers Biosciences (AKER) 3.69 $AKER

Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
GlobeNewswire - Mon Jul 28, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a feasibility study deal with Konica Minolta, Inc. ("Konica Minolta"

to develop a rapid test for the early detection of cardiac muscle tissue damage - a condition commonly observed in patients suffering myocardial infarction (heart attacks). Heart attacks are the leading cause of death in U.S, with approximately 1.1 million Americans suffering heart attacks each year.

US Patent Granted for Akers' Breath Ketone Detection Device
GlobeNewswire - Thu Jul 17, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that the United States Patent and Trademark Office ("USPTO"

has granted a patent covering Akers' Breath Ketone detection device.

Akers to Ring Today's NASDAQ Closing Bell
GlobeNewswire - Wed Jul 09, 7:09AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that the Company's Board of Directors, led by Raymond F. Akers Jr., Ph.D., Co-founder and Executive Chairman, will ring The NASDAQ Closing Bell this afternoon in celebration of Akers' January 23, 2014 listing on The NASDAQ Capital Market.

RedChip Issues Research Profile on Akers Biosciences
GlobeNewswire - Tue Jul 08, 9:03AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.

Akers Biosciences Inc (NASDAQ: AKER) to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Tue Jul 08, 9:00AM CDT
What:

Akers Biosciences Signs Agreement With Medline -- a Major US Distributor
GlobeNewswire - Wed Jun 25, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces a distribution agreement (the "Agreement"

for the Company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries Inc. ("Medline"

, the largest privately held distributor of healthcare supplies in the United States.

Akers Biosciences Signs US Distribution Agreement With Typenex
GlobeNewswire - Wed Jun 04, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that the Company has entered into a sales and distribution agreement for the US, that can be renewed after one year by mutual consent (the "Agreement"

, with Typenex Medical, LLC ("Typenex"

of Chicago, Illinois for the Company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests ("PIFA Heparin Tests"

.

Akers Biosciences Announces Its Financial Results for Fiscal 2013
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Akers Biosciences, Inc. (AKR.L) (Nasdaq:AKER), (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the fiscal year ended December 31, 2013.

Leading Medical Sales and Marketing Executive to Spearhead Akers Biosciences' Commercialization Strategy
GlobeNewswire - Thu Mar 27, 6:00AM CDT
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the appointment of Edwin C. Hendrick as Executive Vice President, Sales and Marketing.

Akers Biosciences Co-Founder and Executive Chairman to Assume Duties of President & CEO
GlobeNewswire - Wed Mar 12, 12:15PM CDT
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, today announces that President and CEO Thomas A. Nicolette will be stepping down from the board and leaving the Company, effective March 28, 2014. Mr. Nicolette is the principal of Nicolette Consulting Group Limited, a business management consulting firm specializing in capital raising and financial planning. Through a series of consulting agreements, Mr. Nicolette has held the position of ABI's President since February 2007 and Chief Executive Officer since April 2008. Most recently, he played an integral role in ABI's successful listing on the NASDAQ Capital Market raising $15 million to support ABI's growth. Raymond F. Akers, Jr. PhD, the Company's Co-founder and Executive Chairman of the Board will assume the duties of President and CEO effective March 28, 2014; Mr. Nicolette will assist in the transition.

Akers Biosciences, Inc. Announces Pricing of Public Offering of Common Stock and Listing on NASDAQ
GlobeNewswire - Thu Jan 23, 12:05PM CST
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "Akers Biosciences), a leading designer and manufacturer of rapid diagnostic screening and testing products, today announced the pricing of an underwritten public offering of 2,727,000 shares (the "Shares"

of common stock at a public offering price of $5.50 per share. The shares will begin trading on The NASDAQ Capital Market on January 23, 2014 at approximately 2:10 PM EST under the symbol "AKER." The Company expects to receive approximately $15,000,000 in gross proceeds, before underwriting discounts and commissions and offering expenses payable by the Company. The Company has granted the representative of the underwriters a 45-day option to purchase up to 409,050 additional shares of common stock.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WareSpace Expands Reach With $36.5M Acquisitions

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

EnGenius Names Experienced VP to Boost Sales Growth

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Airswift's Strategic Acquisition Boosts U.S. Energy Presence

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Chad Tucker's Sequel Explores Deep Spiritual Themes

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Foodcare Proves Effective in Reducing Blood Sugar Levels

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Andover Audio's FreePlay: Stereo Sound Goes Portable

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Omneky Integrates AI Growth Agent With Slack for Ads

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Trust vs. AI: Shapira's Fight in Modern Speechcraft

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...